Showing 3861-3870 of 10623 results for "".
Tourette’s Syndrome
https://reachmd.com/programs/clinicians-roundtable/tourettes-syndrome/1646/Tourette’s syndrome is an inherited neurobehavioral disorder characterized by sudden, involuntary, repetitive muscle movements (motor tics) and vocalizations (vocal tics). Dr. Joseph Jankovic, professor of neurology and distinguished chair in movement disorders at the Baylor College of Medicine, proAdvancing Regenerative Medicine: A Supplement to Modern Aesthetics
https://reachmd.com/topics/regenerative-medicine/advancing-regenerative-medicine-a-supplement-to-modern-aesthetics/56869/Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
https://reachmd.com/programs/medical-industry-feature/immune-imprinting-and-vaccines-rethinking-the-first-exposure-to-influenza/26669/Discover the potential role of immune imprinting in shaping how we approach influenza vaccination.Elevating Clinical Efficiency
https://reachmd.com/programs/empower/elevating-clinical-efficiency/48685/Innovative strategies for the modern optometric practice.The Impact of Advocacy on Healthcare
https://reachmd.com/programs/project-oncology/the-impact-of-advocacy-on-healthcare/24502/Why is advocacy important to the healthcare field? Tune in.Pan-Coronavirus Vaccine Shows Broad Protection Against SARS-CoV-2 Variants
https://reachmd.com/programs/clinicians-roundtable/pan-coronavirus-vaccine-protection-sars-cov-2-variants/48838/ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
https://reachmd.com/programs/project-oncology/esti-pulmonary-nodule-management-lung-cancer-screening/56339/Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
https://reachmd.com/programs/project-oncology/dexamethasone-her-2-positive-breast-cancer/48766/Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
https://reachmd.com/programs/living-rheum/delaying-rheumatoid-arthritis-with-abatacept-ariaa-trial-findings/32799/DOR/ISL Two-Drug Regimen for HIV-1 Is Non-Inferior to BIC/FTC/TAF
https://reachmd.com/programs/clinicians-roundtable/dorisl-two-drug-regimen-for-hiv-1-is-non-inferior-to-bicftctaf/32856/